Drug Shortage Report for BREVIBLOC INJECTION 10MG/ML

Last updated on 2018-05-16 History
Report ID 43037
Drug Identification Number 02188880
Brand name BREVIBLOC INJECTION 10MG/ML
Common or Proper name Brevibloc Injection
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) ESMOLOL HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10mL vials
ATC code C07AB
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-09
Actual start date 2018-03-27
Estimated end date 2018-05-09
Actual end date 2018-05-09
Shortage status Resolved
Updated date 2018-05-16
Company comments For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-03-15 English Compare
v2 2018-03-15 French Compare
v3 2018-03-16 English Compare
v4 2018-03-16 French Compare
v5 2018-03-28 English Compare
v6 2018-03-28 French Compare
v7 2018-04-13 English Compare
v8 2018-04-13 French Compare
v9 2018-05-16 English Compare
v10 2018-05-16 French Compare

Showing 1 to 10 of 10